Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Mechanism of action of recombinant factor VIIa.

× No keyword cloud information.

16 in total

Review 1. Managing anticoagulant related coagulopathy.

Authors: Amir K Jaffer
Journal: J Thromb Thrombolysis Date: 2007-10-17 Impact factor: 2.300

Review 2. Recombinant factor VIIa: a review on its clinical use.

Authors: Massimo Franchini
Journal: Int J Hematol Date: 2006-02 Impact factor: 2.490

Review 3. The use of recombinant activated factor VII in platelet disorders: a critical review of the literature.

Authors: Massimo Franchini
Journal: Blood Transfus Date: 2009-01 Impact factor: 3.443

Review 4. Recombinant factor VIIa as haemostatic therapy in advanced liver disease.

Authors: Pier Mannuccio Mannucci; Massimo Franchini
Journal: Blood Transfus Date: 2012-10-10 Impact factor: 3.443

5. The expanding role of prophylaxis with recombinant activated factor VII.

Authors: Annarita Tagliaferri; Massimo Franchini
Journal: Blood Transfus Date: 2012-07-04 Impact factor: 3.443

6. Redistribution and hemostatic action of recombinant activated factor VII associated with platelets.

Authors: Irene Lopez-Vilchez; Ulla Hedner; Carmen Altisent; Maribel Diaz-Ricart; Gines Escolar; Ana M Galan
Journal: Am J Pathol Date: 2011-06 Impact factor: 4.307

7. Disulfide locked variants of factor VIIa with a restricted beta-strand conformation have enhanced enzymatic activity.

Authors: Henry R Maun; Charles Eigenbrot; Helga Raab; David Arnott; Lilian Phu; Sherron Bullens; Robert A Lazarus
Journal: Protein Sci Date: 2005-05 Impact factor: 6.725

8. Recombinant human factor VIIa (rFVIIa) cleared principally by antithrombin following intravenous administration in hemophilia patients.

Authors: H Agersø; D F Brophy; H Pelzer; E J Martin; M Carr; U Hedner; M Ezban
Journal: J Thromb Haemost Date: 2011-02 Impact factor: 5.824

9. Activated recombinant factor VIIa should not be used in patients with refractory variceal bleeding: it is mostly ineffective, is expensive, and may rarely cause serious adverse events.

Authors: Margaret S Sozio; Naga Chalasani
Journal: Hepatology Date: 2014-10-02 Impact factor: 17.425

Review 10. Dose titration of recombinant factor VIIa using thromboelastograph monitoring in a child with hemophilia and high titer inhibitors to factor VIII: a case report and brief review.

Authors: Cody C Trowbridge; Alfred H Stammers; Nancy Ciccarelli; Myra Klayman
Journal: J Extra Corpor Technol Date: 2006-09